Daniel L. Miller, MD, PhD

Washington University in St. Louis (WU)

My clinical and research interests center on advancing the diagnosis, classification, and prognostication of thyroid cancer, endocrine and neuroendocrine tumors, and head and neck malignancies. I focus on integrating histopathology, cytopathology, and molecular diagnostics to refine risk stratification and guide precision treatment—particularly in diagnostically challenging or rare tumor types. My work emphasizes the biology of squamous cell carcinoma, thyroid neoplasms, and biomarker-driven approaches to endocrine and neuroendocrine tumors. I am also committed to collaborative translational research that applies genomic and epigenetic profiling, immunohistochemistry, and digital pathology to understand tumor invasion, progression, and therapeutic vulnerabilities. Through these efforts, I aim to improve patient outcomes by bridging diagnostic pathology with molecular insights and fostering multidisciplinary strategies for cancer management.